logo

FDA Calendar

Share
Company Name ACADIA Pharmaceuticals Inc
Drug Name NUPLAZID (sNDA)
Event Name FDA decision on NUPLAZID for the treatment of hallucinations and delusions associated with dementia-related psychosis
Event Date 04/03/2021
Outcome Date
Outcome
Drug Status
Rival Drugs
Market Potential
Other Approvals NUPLAZID is already approved for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.
News
Return to FDA Calendar